Regenerative technologies to bed side: Evolving the regulatory framework
Open Access
- 1 April 2017
- journal article
- review article
- Published by Elsevier in Journal of Orthopaedic Translation
- Vol. 9, 1-7
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Japan’s regulatory gamble and what it means for the IndustryCell & Gene Therapy Insights, 2015
- RIKEN suspends first clinical trial involving induced pluripotent stem cellsNature Biotechnology, 2015
- Rapidly rising clinical trial costs worry researchersCanadian Medical Association Journal, 2009
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006